Siolta Therapeutics: Funding, Investors & Team (Sep 2026)
Siolta Therapeutics develops human microbiome therapeutics to prevent and treat inflammatory diseases by leveraging its expertise in the gut microbiome and immune tolerance. The company creates targeted microbial therapeutics and diagnostics for medical researchers to use in preventing and treating inflammatory diseases with information from human microbiome studies. This allows them to design advanced microbial therapies to stop inflammation.
Siolta Therapeutics has raised $42.1M across 3 funding rounds on record, the most recent an undisclosed round of $12.0M announced in Mar 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Siolta Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2024.
Siolta Therapeutics Funding Rounds
Siolta Therapeutics raised $30.0M in an undisclosed round announced in Sep 2020.
1.4 years later, a Grant of $100k was announced in Feb 2022.
2.1 years later, an undisclosed round of $12.0M was announced in Mar 2024.
Siolta Therapeutics Founders and Leadership Team
Contact details for the Siolta Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Siolta Therapeutics Funding Compared to Other Biotechnology Startups
Siolta Therapeutics' latest round of $12.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Siolta Therapeutics in Biotechnology and San Carlos
Companies Similar to Siolta Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Siolta Therapeutics Funding FAQs
What does Siolta Therapeutics do?
Siolta Therapeutics develops human microbiome therapeutics to prevent and treat inflammatory diseases by leveraging its expertise in the gut microbiome and immune tolerance. The company creates targeted microbial therapeutics and diagnostics for medical researchers to use in preventing and treating inflammatory diseases with information from human microbiome studies. This allows them to design advanced microbial therapies to stop inflammation.
How much funding has Siolta Therapeutics raised?
Siolta Therapeutics has raised $42.1M across 3 rounds on record. The most recent is an undisclosed round of $12.0M announced in Mar 2024.
When did Siolta Therapeutics last raise funding?
Siolta Therapeutics' most recent funding round on record is an undisclosed round of $12.0M, announced in Mar 2024.
Who is the CEO of Siolta Therapeutics?
Nikole Kimes is listed as CEO at Siolta Therapeutics.
Where is Siolta Therapeutics headquartered?
Siolta Therapeutics is based in San Carlos, California, United States.
How many employees does Siolta Therapeutics have?
Siolta Therapeutics is in the 11-50 employee band.
How does Siolta Therapeutics' funding compare to other Biotechnology startups?
Siolta Therapeutics' latest round of $12.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Siolta Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Siolta Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.